Charles Theuer

Insider Reports History

Entity
Individual
Location
C/O Tracon Pharmaceuticals, Inc., 4350 La Jolla Village Drive, Suite 800, San Diego, CA
Signature
/s/Chase C. Leavitt, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Theuer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tracon Pharmaceuticals, Inc. PRESIDENT AND CEO, Director Common Stock 406K $54.2K $0.13 Oct 20, 2023 Direct
Tracon Pharmaceuticals, Inc. PRESIDENT AND CEO, Director Employee Stock Option (Right to Buy) 518K Mar 12, 2024 Direct
4D Molecular Therapeutics, Inc. Director Stock Option (Right To Buy) 22.5K May 21, 2024 Direct
Oncternal Therapeutics, Inc. Director Stock Options 2.2K Jun 20, 2024 Direct

Insider Reports Filed by Charles Theuer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONCT Oncternal Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
FDMT 4D Molecular Therapeutics, Inc. May 21, 2024 1 $0 4 May 23, 2024 Director
TCON Tracon Pharmaceuticals, Inc. Mar 12, 2024 3 $949 4 Mar 13, 2024 PRESIDENT AND CEO, Director
ONCT Oncternal Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 30, 2023 Director
FDMT 4D Molecular Therapeutics, Inc. May 23, 2023 1 $0 4 May 25, 2023 Director
TCON Tracon Pharmaceuticals, Inc. Apr 26, 2023 2 $37.9K 4 Apr 28, 2023 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Feb 28, 2023 2 $7.6K 4 Mar 2, 2023 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 3, 2023 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Jan 18, 2023 1 $11K 4 Jan 19, 2023 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Dec 14, 2022 1 $29.8K 4 Dec 15, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Nov 18, 2022 1 $19.6K 4 Nov 22, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Nov 3, 2022 1 $14K 4 Nov 4, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Nov 2, 2022 1 $9.54K 4 Nov 3, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Oct 7, 2022 1 $8.85K 4 Oct 11, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Oct 3, 2022 1 $8.35K 4 Oct 5, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Sep 22, 2022 1 $8.8K 4 Sep 26, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Jul 22, 2022 1 $8.33K 4 Jul 25, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Jul 12, 2022 2 $11.1K 4 Jul 14, 2022 President and CEO, Director
ONCT Oncternal Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
FDMT 4D Molecular Therapeutics, Inc. May 23, 2022 1 $0 4 May 25, 2022 Director
TCON Tracon Pharmaceuticals, Inc. May 9, 2022 1 $18.5K 4 May 11, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. May 6, 2022 1 $4.93K 4 May 10, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Apr 29, 2022 1 $9.85K 4 May 3, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Apr 21, 2022 1 $10.4K 4 Apr 25, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Apr 8, 2022 1 $5K 4 Apr 12, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Mar 30, 2022 1 $10.8K 4 Apr 1, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Mar 21, 2022 1 $2.94K 4 Mar 23, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Jan 28, 2022 1 $0 4 Feb 1, 2022 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Nov 18, 2021 2 $11.8K 4 Nov 22, 2021 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Nov 5, 2021 2 $13.7K 4 Nov 9, 2021 President and CEO, Director
TCON Tracon Pharmaceuticals, Inc. Aug 16, 2021 1 $10.7K 4 Aug 18, 2021 President and CEO, Director
ONCT Oncternal Therapeutics, Inc. May 25, 2021 1 $0 4 May 27, 2021 Director
FDMT 4D Molecular Therapeutics Inc. May 17, 2021 1 $0 4 May 19, 2021 Director